About Cogentix Medical
Cogentix Medical is a Healthcare company based in Orangeburg (United States) founded in 1987, and was acquired by Laborie Medical in February 2018. Minimally invasive treatment of voiding dysfunctions and endoscopy solution. Cogentix Medical has raised $25 million across 1 funding round from investors including Laborie Medical and Accelmed. The company has 141 employees. The company was acqui-hired. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its legal entity is COGENTIX MEDICAL INC /DE/. Its competitors include Amphora Medical, EMKinetics and Valencia Technologies; 3 of its 3 listed competitors have raised funding.
Company details
Cogentix Medical develops prescription-only (Rx) mininally invasive products used in the treatment of voiding dysfunctions and endoscopy solutions. The products include the Urgent PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and Urinal Incontinence (an FDA-cleared system that is also indicated for the treatment of fecal incontinence outside the US market); Macroplastique - for Stress Urinary Incontinence (SUI);and EndoSheath Endoscopy- an FDA-cleared, sterile, single-use product.
- Headquarters Orangeburg, United States
- Employees 141
- Stage Acquired
- SectorsHealthcare
- Website cogentixmedical.com
- Social LinkedIn X Facebook
- Acquired by Laborie Medical (Feb 2018)
- Legal Name Cogentix Medical Inc /De/
- Annual Revenue$56.32 M (USD)9as on Dec 31, 2017
- Net Profit-$882.75 K (USD)96as on Dec 31, 2017
- EBITDA-$889.47 K (USD)51as on Dec 31, 2017
- Total Equity Funding$25M (USD)
in 1 rounds
- Latest Funding Round$25M (USD), Private Equity Round
Sep 2016
- InvestorsLaborie Medical
& 1 more
- Employee Count141
- Acquired byLaborie Medical
(Feb 2018)
Funding Insights of Cogentix Medical
Cogentix Medical has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $25 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25M
- Total Rounds 1
- Last Round Private Equity Round — $25M
- First Round $25M
(Sep 2016)
- Investors Count 1
All 1 funding rounds of Cogentix Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $25M | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Cogentix Medical
Cogentix Medical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Laborie Medical and Accelmed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| accelmed.com | ||||
Medical products for female lower urinary tract dysfunctions are provided. | 1967 | laborie.com | Mississauga, Canada |
Investor details for Cogentix Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cogentix Medical
3 dated milestones of Cogentix Medical across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Cogentix Medical is founded.
- Funding First funding round of $25.0M.
- Exit Acquired by Laborie Medical.
Competitors of Cogentix Medical
Cogentix Medical has 3 listed competitors in our database, 3 of them funded. They include Amphora Medical, EMKinetics and Valencia Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amphoramedical.com | 2011 | Minneapolis, United States | $48.28M | 12 | Radiofrequency ablation device for overactive bladder treatment | |
| emkinetics.com | 2006 | San Francisco, United States | $12.53M | Transdermal stimulation therapy is provided for urinary incontinence treatment. | ||
| valenciatechnologies.com | 2011 | Santa Clarita, United States | $54.97M | A coin-sized neuromodulation device for hypertension treatment is developed. |
Detailed competitors of Cogentix Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as Cogentix Medical (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cogentix Medical
Complete news archive for Cogentix Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cogentix Medical
Cogentix Medical was founded in 1987 and raised its 1st funding round 29 years after it was founded.
Cogentix Medical is headquartered in Orangeburg, United States. It is registered at Orangeburg, South Carolina, United States.
Cogentix Medical is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $25M, raised on Sep 2016.
Cogentix Medical has 141 employees.
Annual revenue of Cogentix Medical is $56.32M as on Dec 31, 2017.
Cogentix Medical develops prescription-only (Rx) mininally invasive products used in the treatment of voiding dysfunctions and endoscopy solutions. The products include the Urgent PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and Urinal Incontinence (an FDA-cleared system that is also indicated for the treatment of fecal incontinence outside the US market); Macroplastique - for Stress Urinary Incontinence (SUI);and EndoSheath Endoscopy- an FDA-cleared, sterile, single-use product.
Cogentix Medical's top competitors include Valencia Technologies, Amphora Medical and EMKinetics.
Cogentix Medical has 2 investors. Key investors include Laborie Medical, and Accelmed.
Cogentix Medical operates through Cogentix Medical Inc /De/.
Yes. Cogentix Medical was acquired by Laborie Medical in February 2018.